Introduction
============

Lung cancer, as a common malignant tumor, is part of the leading causes of cancer-related death worldwide ([@ref-25]). Non-small cell lung cancer (NSCLC) is the most frequent subtype of lung cancer, LSCC as a histologic subtype of NSCLC accounts for more than 40% of the annual confirmed cases of lung cancer ([@ref-19]). Currently, the treatment and prognostic evaluation of LSCC mainly hinges on TNM stage, and surgical resection is the most suitable treatment for patients with early LSCC ([@ref-9]). However, although surgical resection improved survival, recurrence took place in nearly a quarter of patients ([@ref-2]; [@ref-10]). Therefore, it is extremely important to accurately assess the recurrent risk in LSCC patients.

The infiltration of immune cells in the tumor is closely related to clinical consequences, and most likely to be used as drug targets to improve the survival rate of patients. Immunocheckpoint therapy is a type of therapy to improve the anti-tumor immune response by regulating T cell activity through co-inhibition or co-stimulation, which shows significant clinical effects ([@ref-7]; [@ref-15]; [@ref-16]; [@ref-24]). With the development of immunocheckpoint therapy, the distribution of infiltrating immune cells in tumors has been the subject of research. Previous studies have primarily used flow cytometry or immunohistochemistry to assess the composition of infiltrating immune cells in tumors, but these methods have their limitations. Researchers recently developed a new bioinformatics tool called CIBERSORT ([@ref-5]). CIBERSORT, a deconvolution algorithm improved by [@ref-3], can estimate the cell composition of composite tissues based on standardized gene expression data. This method can quantify the abundance of specific cell types and has been properly validated by flow cytometry. The composition of immune cells in breast and liver cancer tissues has been successfully assessed by this method ([@ref-1]; [@ref-22]). [@ref-1] showed that the difference of immune infiltrating cell composition in breast cancer may be an important factor in determining prognosis and treatment response. [@ref-22] reported that monocytes, activated mast cells and plasma cells were decreased in HCC, while naïve B cells, resting mast cells, CD8+ T cells and CD4+ memory resting were increased when compared to healthy livers. In this study, gene expression data from 502 patients with LSCC based on the TCGA database were analyzed. CIBERSORT was used to assess the proportion of 22 immune cell types in tumor samples and to analyze their relationship with overall survival.

Material and Methods
====================

Data acquisition
----------------

Training cohort of LSCC for this study were obtained from the shared database TCGA (The Cancer Genome Atlas) ([@ref-8]; [@ref-23]; [@ref-26]). We downloaded transcription data of 502 patients with LSCC from the TCGA database by typing the keyword "lung squamous cell carcinoma" of UCSC Xena website (<https://xenabrowser.net/>). These included 49 cases of normal lung tissue and 436 cases of LSCC. Secondly, we also obtained the quantifiable information including prognostic information, age, gender, stage, TNM stage and so on. Finally, we utilized the "lemma" package in R software to calibrate the transcription data of LSCC.

Evaluation of tumor infiltrating immune cells
---------------------------------------------

CIBERSORT is a deconvolution algorithm utilizing 547 labeled gene expression values to determine the proportion of 22 immune cells in tissues ([@ref-11]; [@ref-16]). In this study, we used this algorithm to calculate the proportion of 22 infiltrating immune cells in LSCC tissues. We upload corrected transcription data to CIBERSORT website (<http://cibersort.stanford.edu/>). Each sample in the data set will get a *P* value, and samples with a *P* value less than 0.05 will be selected for further study.

Statistical analyses
--------------------

SPSS 23.0 (IBM, Armonk, NY, USA) and R 3.5.3 ([@ref-20]) were used for analysis. All statistical tests were bilateral, and a *P* value less than 0.05 was studied statistically significant. Continuous variables having to be in conformity with customary distribution were compared by independent *t* test, while continuous variables with skewed distribution were compared by Mann--Whitney *U* test. Pearson's correlation analysis and spearman's correlation analysis was employed in the correlation analysis. The Kaplan-Meier curve was utilized to analyze the relationship between immune risk score and overall survival. Log-rank test is employed to evaluation. Immune risk score model was constructed based on TIICs correlated with LSCC-related recurrence. Multivariate cox regression analysis was used to investigate whether the immune risk score was an independent factor for prognosis prediction of LSCC. The nomogram was under construction to comprehensively predict the survival rate of LSCC.

Results
=======

The landscape of immune infiltration in LSCC
--------------------------------------------

CIBERSORT algorithm was used to screen out samples with CIBERSORT output *P* value less than 0.05 for research, and 485 samples including 49 normal lung tissues and 436 LSCC tissues were screened out. We plotted bar plot to demonstrate the proportion of 22 immune cells in each sample ([Fig. 1A](#fig-1){ref-type="fig"}). The results revealed that the five immune cells with the highest proportion in LSCC were M0 Macrophages (21.0%), M2 Macrophages (16.8%), Plasma cells (11.0%), resting memory CD4+ T cells (10%) and naive B cells (9.0%). Then, we plot the heat map of 22 immune cells in [Fig. 1B](#fig-1){ref-type="fig"}. [Figure 1C](#fig-1){ref-type="fig"} indicated the correlation coefficient between 22 immune cells, among which naive B cells and memory B cells have the strongest positive correlation (*r* = 0.58), resting memory CD4+ T cells had the strongest negative correlation with follicular helper T cells (*r* =  − 0.53).

![The landscape of Tumor-infiltrating immune cells in LSCC.\
(A) The proportion of 22 immune cells in LSCC tissues. (B) The heat maps of 22 immune cells in LSCC tissues, the horizontal axis shows the clustering information of samples which were divided into two major clusters. (C) Correlation matrix between 22 immune cells in LSCC, red means positive correlation, blue means negative correlation, and the darker the color, the stronger the correlation.](peerj-07-7918-g001){#fig-1}

The different proportion of 22 immune cells in normal lung tissue and LSCC
--------------------------------------------------------------------------

We compared the differential infiltration of 22 immune cells between normal lung tissues and LSCC tissues. The results showed that except for memory B cells, naive CD4+T cells, gamma delta T cells and activated NK cells, the remaining immune cells were infiltrated differently in normal lung tissues and LSCC tissues (*p* \< 0.05, [Fig. 2A](#fig-2){ref-type="fig"}). The results of principal component analysis showed that there are significant individual differences between normal lung tissues and LSCC tissues (*p* \< 0.05, [Fig. 2B](#fig-2){ref-type="fig"}).

![The different proportion of 22 immune cells in normal lung tissue and LSCC tissue.\
(A) Variance analysis, blue represents normal lung tissue, and red represents LSCC tissue. (B) Principal component analysis, the first two principal components which explain the most of the data variation are shown.](peerj-07-7918-g002){#fig-2}

Predictive value of TIICs in LSCC
---------------------------------

Kaplan--Meier analysis was utilized to investigate the prognostic value of 22 tumours infiltrating immune cells in LSCC tissues. We can find that high infiltration of activated mast cells (*P* = 0.041) and follicular helper T cells (*P* = 0.009) in LSCC tissues are linked to poor prognosis ([Fig. 3B](#fig-3){ref-type="fig"}).

![(A--V) Prognostic value of 22 immune cells in LSCC by Kaplan--Meier analysis, high infiltration of activated mast cells and follicular helper T cells in LSCC tissues are linked to poor prognosis.](peerj-07-7918-g003){#fig-3}

Establishment of immune risk score model
----------------------------------------

Multivariate Cox PHR was carried out to construct an excepted risk score model based on resting memory CD4+T cells, activated mast cells and follicular helper T cells selected by forward stepwise regression analysis. Formula is this: Risk3 = −3.03 \* resting memory CD4 + T cells −15.26 \* activated mast cells −21.67 \* follicular helper T cells ([Table 1](#table-1){ref-type="table"}). Each sample will be paid a risk score built on the model. Patients were divided into a high-risk group and a low-risk group according to the median risk score. Kaplan--Meier curves indicated that patients in the high-risk group had a poorer prognosis than those in the low-risk group (*p* = 8.277e−03, [Fig. 4A](#fig-4){ref-type="fig"}). The ROC curve showed that the immune risk score model is reliable to predict the prognosis of patients with LSCC (AUC=0.614, [Fig. 4B](#fig-4){ref-type="fig"}). In addition, [Figures 4C](#fig-4){ref-type="fig"}, [4D](#fig-4){ref-type="fig"} and [4E](#fig-4){ref-type="fig"} respectively showed the risk score, survival status and three immune cells infiltration of patients with LSCC.

10.7717/peerj.7918/table-1

###### Multivariate Cox PHR based on 3 immune cells.

![](peerj-07-7918-g006)

  id                           Coef       HR         HR.95L     HR.95H     *p* value
  ---------------------------- ---------- ---------- ---------- ---------- -----------
  T cells CD4 memory resting   −3.03219   0.04821    0.002677   0.868148   0.039799
  T cells follicular helper    −15.2555   2.37E−07   2.34E−11   0.002394   0.001184
  Mast cells resting           −21.6671   3.89E−10   3.29E−22   459.8077   0.126588

**Notes.**

AbbreviationsHRhazard ratio

![Establishment of immune risk scores model.\
(A) Kaplan--Meier survival curves of overall survival between high-risk and low-risk patients. (B) ROC curve AUC statistics assess the predictive power of the immune risk score model. (C) The distribution of patients' risk score. (D) The distribution of patients' survival state. (E) Three immune cell infiltration of patients with LSCC.](peerj-07-7918-g004){#fig-4}

Independent predictive power of immune risk score model
-------------------------------------------------------

Multivariate analysis was used to investigate whether the risk score as predictors of overall survival was independent of other clinicopathological data such as age, gender and clinical stage. The results suggested that the risk score (HR = 1.30, 95% CI \[1.20--1.40\]; *P* \< 0.001) and clinical stage (HR = 1.70, 95% CI \[1.49--2.10\]; *P* \< 0.001) are two independent predictors of overall survival in LSCC patients ([Table 2](#table-2){ref-type="table"}).

10.7717/peerj.7918/table-2

###### Independent predictive power of immune risk score model.

![](peerj-07-7918-g007)

  id          Univariate analysis   Multivariate analysis                                        
  ----------- --------------------- ----------------------- ------ -------- ------ ------ ------ --------
  RiskScore   2.78                  1.63                    4.74   0.0002   2.99   1.65   5.4    0.0003
  Sex         0.8                   0.56                    1.12   0.19     0.67   0.46   0.99   0.048
  T           1.26                  1.05                    1.52   0.014    0.98   0.71   1.36   0.9
  N           1.16                  0.94                    1.43   0.16     0.97   0.64   1.46   0.88
  M           3.03                  1.11                    8.21   0.03     1.08   0.27   4.34   0.92
  Stage       1.24                  1.04                    1.49   0.02     1.31   0.83   2.06   0.25
  Age         1.02                  1                       1.04   0.01     1.03   1.01   1.06   0.003

**Notes.**

AbbreviationsHRhazard ratio

Correlation between immune risk score and clinicopathological parameters
------------------------------------------------------------------------

To analyze the correlation between immune risk score (IRS) and clinicopathological parameters in 436 LSCC samples. The results revealed that immune risk score is associated with T stage of LSCC, while there was no correlation between the patient's immune risk score and clinicopathological parameters such as age, gender, clinical stage, N stage and M stage (*P* \> 0.05, [Table 3](#table-3){ref-type="table"}).

10.7717/peerj.7918/table-3

###### Correlation between the immune risk score and clinicopathological parameters.

![](peerj-07-7918-g008)

  Item              Mean IRS value   *P*
  -------- -------- ---------------- ------
  Age      \<68     1.07             0.34
           \>68     1.01             
  Stage    I        1.05             0.9
           II       1.08             
           III      1.03             
           IV       1.09             
  Gender   Female   1.05             0.96
           Male     1.05             
  T        T1       1                0.03
           T2       1.07             
           T3       1.08             
           T4       0.94             
  N        N0       1.05             0.69
           N1       1.06             
           N2       1.04             
           N3       1.15             
  M        M0       1.06             0.98
           M1       1.09             

**Notes.**

AbbreviationsIRSimmune risk score

Construction of nomogram model
------------------------------

In order to take full advantage of the clinicopathological parameters of LSCC and the excepted risk model to predict the survival rates of LSCC patients, we constructed a nomogram. We can take note of the prognosis of patients according to clinicopathological parameters and immune risk model. Then, total scores were used to evaluate 3-year survival in patients with LSCC ([Fig. 5](#fig-5){ref-type="fig"}).

![Construction of the nomogram model, each variable axis represented an individual risk factor, and the line drawn upwards was used to determine the points of each variable.\
Then the total points would be calculated to obtain the probability of 1-, 2- and 3-year OS.](peerj-07-7918-g005){#fig-5}

Discussion
==========

Built on the "seed and soil" theory of cancer metastasis proposed by Paget, cancer cells, as "seed", depend on the surrounding microenvironment "soil" for their occurrence and metastasis ([@ref-18]). Tumor microenvironment (TME) relates to bioactive molecules secreted by extra-cellular matrix (ECM), stomatal cells, tumor and stomatal cells, as well as lymphatic and vascular systems ([@ref-12]). On the one hand, tumor cells affect the surrounding microenvironment by autocrine and paracrine to continue their invasion, growth and tumor formation. On the other hand, various cells and extracellular matrix in tumor microenvironment play an important role in tumor development, invasion, metastasis and tumor treatment. Nowadays, a series of studies have shown that tumor immune cells as an important component of tumor microenvironment play a major role in tumor prognosis. For example, [@ref-14] stated that Tregs T cells and M2 macrophages have different prognostic values in gastric cancer patients with distinct clinicopathological characteristics and chemotherapy strategies. Elevated tumor infiltrating lymphocytes were significantly related to better survival in colorectal cancer ([@ref-13]).

At present, the conventional surgical method utilised for the treatment of LSCC is still resection. Being dependent on the investigation data, there is still a high recurrence rate after the resection of LSCC ([@ref-27]). Therefore, it is of profound significance to study the factors affecting the prognosis of LSCC patients to increase their long-term survival. To explore the prognostic value of tumor infiltrating immune cells in LSCC, CIBERSORT algorithm was used to calculate the proportion of 22 infiltrating immune cells in LSCC tissues, and samples with *P* value less than 0.05 were selected for this study. Kaplan--Meier analysis of 22 immune cells showed that activated mast cells were linked to poor prognosis of LSCC, while follicular helper T cells were associated with a better outcome of LSCC. Mast cells, as an important component of tumor microenvironment, have been proved to exist in a large number of solid tumors ([@ref-17]; [@ref-21]). Mast cells play both positive and negative roles in tumors, depending on bioactive substances secreted ([@ref-21]). A large number of studies have shown that high infiltration mast cells in tumors are associated with a good prognosis of patients ([@ref-4]; [@ref-6]; [@ref-28]), which runs counter to our results. Follicular helper T cells induce B cells to begin antibody responses outside the follicle and the germinal center. Previous studies have shown that invasive follicular helper T cells have a protective effect in colorectal cancer and breast cancer, which are substantially corelated with patient survival ([@ref-29]). A multivariate cox regression model was used to construct the immune risk score model based on resting memory CD4+T cells, activated mast cells and follicular helper T cells selected by forward stepwise regression analysis, and the ROC curve indicated that the model was reliable in predicting the recurrence risk of LSCC. In addition, we tried to look for datasets in the GEO database to validate our results, but due to the limited number of LSCC patients, we were unable to make meaningful validation results. Given the rapid development of high-throughput technologies, it is reasonable to suppose that our immune risk score model has great potential for transforming clinical practice. In addition, we also found that naive B cells, memory B cells, plasma cells, CD8+T cells, memory CD4+T cells, trees T cells, resting NK cells, mast cells, monocytes cells and other cells had no statistical significance on the prognosis of LSCC. However, these cells show differential expression in normal lung tissues and LSCC tissues, suggesting that they are closely connected with the occurrence and progress of LSCC. Besides, correlation analysis showed that immune risk score is associated with T stage of LSCC, while there was no correlation between the patient's immune risk score and clinicopathological parameters such as age, gender, clinical stage, N stage and M stage. The result indicated that the immune risk score is associated with local infiltration of LSCC, but not with distant metastasis. Finally, a nomogram model was constructed to predict the survival rates of LSCC patients. The line segment length corresponding to each variable in the nomogram represents the contribution of predictors to survival outcome. The immune risk score has the greatest effect on prognosis, while T stage has a smaller effect on prognosis compared with other factors. In future studies, external data should be used to verify the wide applicability of the nomogram.

Conclusion
==========

In conclusion, the present study demonstrated the prognostic value of 22 immune cells in LSCC. The immune risk score model was reliable for predicting the prognosis of LSCC based on the TCGA database, and the risk score model was an independent factor affecting the prognosis of LSCC. However, due to the limited number of LSCC patients, this immune risk score model could not be verified in GEO database. It is hoped that sufficient samples can be collected in future studies to verify this result.
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